Affiliation:
1. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
2. The Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD
Abstract
OBJECTIVE
Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults, and although screening with eye exams is effective, screening rates are low. We evaluated eye exam visits over a 5-year period in a large population of insured patients 10–64 years of age with diabetes.
RESEARCH DESIGN AND METHODS
We used claims data from IBM Watson Health to identify patients with diabetes and continuous insurance coverage from 2010 to 2014. Diabetes and DR were defined using ICD-9 Clinical Modification codes. We calculated eye exam visit frequency by diabetes type over a 5-year period and estimated period prevalence and cumulative incidence of DR among those receiving an eye exam.
RESULTS
Among the 298,383 insured patients with type 2 diabetes and no diagnosed DR, almost half had no eye exam visits over the 5-year period and only 15.3% met the American Diabetes Association (ADA) recommendations for annual or biennial eye exams. For the 2,949 patients with type 1 diabetes, one-third had no eye exam visits and 26.3% met ADA recommendations. The 5-year period prevalence and cumulative incidence of DR were 24.4% and 15.8%, respectively, for patients with type 2 diabetes and 54.0% and 33.4% for patients with type 1 diabetes.
CONCLUSIONS
The frequency of eye exams was alarmingly low, adding to the abundant literature that systemic changes in health care may be needed to detect and prevent vision-threatening eye disease among people with diabetes.
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference29 articles.
1. National Eye Institute. Facts about diabetic eye disease [Internet], 2015. Available from https://nei.nih.gov/health/diabetic/retinopathy. Accessed 27 November 2017
2. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus;Vijan;JAMA,2000
3. Cost-effectiveness of detecting and treating diabetic retinopathy;Javitt;Ann Intern Med,1996
4. Disparities in adherence to screening guidelines for diabetic retinopathy in the United States: a comprehensive review and guide for future directions;Fathy;Semin Ophthalmol,2016
5. IBM Watson Health. IBM MarketScan Research Databases [Internet], 2018. Available from https://www-01.ibm.com/common/ssi/cgi-bin/ssialias?htmlfid=HPS03169USEN. Accessed 30 August 2018
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献